H James Harwood, Jr

Title: H James Harwood, Jr: Innovator in Squalene Synthase Inhibition

Introduction

H James Harwood, Jr. is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit squalene synthase. His work is crucial in the treatment of fungal infections, showcasing the intersection of innovation and healthcare.

Latest Patents

Harwood holds a patent for an "Inhibitor of squalene synthase." This patent involves the culture ATCC 74256 and its mutants, which are capable of producing zaragozic acid A and other squalene synthase inhibitors. The compound of formula I may be prepared from culture ATCC 74256 and is useful in the treatment of fungal infections, as well as the inhibition of squalene synthase and protein farnesyltransferase. He has 1 patent to his name.

Career Highlights

Harwood is currently associated with Pfizer Corporation, a leading pharmaceutical company. His role at Pfizer allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in biochemistry and innovative thinking has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Harwood has collaborated with esteemed colleagues, including Thomas T Dabrah and Liang H Huang. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

H James Harwood, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His work on squalene synthase inhibitors not only highlights his inventive capabilities but also underscores the importance of collaboration in scientific research. His contributions continue to impact the treatment of fungal infections and advance the field of biochemistry.